Opus Genetics secures $1.7M in funding from foundation
The Foundation Fighting Blindness has awarded Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, $1.7 million in funding to help advance two preclinical therapy candidates. Opus said the new …